Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz
Gewählte Publikation:
SHR Neuro Krebs Kardio Lipid Stoffw Microb
Bartsch, R; Gampenrieder, SP; Rinnerthaler, G; Petru, E; Egle, D; Petzer, A; Balic, M; Pluschnig, U; Sliwa, T; Singer, C.
Updated Austrian treatment algorithm in HER2+ metastatic breast cancer.
Wien Klin Wochenschr. 2022; 134(1-2):63-72
Doi: 10.1007/s00508-021-01987-9
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
- Balic Marija
- Petru Edgar
- Rinnerthaler Gabriel
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- A group of Austrian breast cancer specialists met in December 2020 to establish a comprehensive clinical benefit-risk profile of available HER2-targeted therapies based on recent data and to develop an updated treatment algorithm by consensus over several months in 2021. A total of four scenarios were developed in which treatment strategies appropriate for specific patient profiles were evaluated. Consensus was established by detailed discussions of each scenario and by reaching full consensus.
- Find related publications in this database (using NLM MeSH Indexing)
- Algorithms - administration & dosage
- Antibodies, Monoclonal, Humanized - therapeutic use
- Antineoplastic Combined Chemotherapy Protocols - administration & dosage
- Austria - administration & dosage
- Breast Neoplasms - drug therapy
- Female - administration & dosage
- Humans - administration & dosage
- Receptor, ErbB-2 - genetics, therapeutic use
- Trastuzumab - therapeutic use
- Find related publications in this database (Keywords)
- HER2
- Trastuzumab
- Pertuzumab
- Antibody-conjugate
- Tyrosin-kinase inhibitor